Whoopi Goldberg mengungkapkan kekesalannya terhadap iklan palsu yang beredar di Instagram yang menggunakan gambarnya untuk ...

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...

Dalam studi yang melibatkan hampir 45.000 peserta ini, para peneliti berupaya memahami faktor utama yang mendorong perkembangan pradiabetes menjadi diabetes.

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...

Could a diabetes and weight loss drug benefit the brain? Here’s what scientists are learning. By Dana G. Smith and Dani Blum Over a decade ago, a smattering of studies suggested that early ...

Jika berbagai usaha Anda untuk memperbaiki kerontokan gagal terus, ada baiknya konsultasikan ke dokter mengenai pilihan obat rambut rontok sesuai dengan penyebabnya. Minoxidil adalah obat yang ...

Ophthalmic complications were observed in patients using semaglutide and tirzepatide, but a causal link was not established. The study included nine patients, with conditions like nonarteritic ...

Manufactured by Eli Lilly and Company, both Mounjaro and Zepbound contain the active ingredient tirzepatide. Tirzepatide is similar to semaglutide, which is used in medications like Ozempic, Rybelsus, ...